SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-22-000360
Filing Date
2022-06-17
Accepted
2022-06-17 16:53:42
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5949
  Complete submission text file 0000904454-22-000360.txt   7338
Mailing Address C/O KERYX BIOPHARMACEUTICALS 750 LEXINGTON AVENUE NEW YORK X1 10022
Business Address
Kaye Jack (Reporting) CIK: 0001376099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 221024679

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations